Actelion Ltd (ALIOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALIOF | AZN | AMGN | GILD | VRTX |
| Company | Actelion Ltd | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 278.3400 | 96.02 | 324.09 | 121.38 | 454.58 |
| High | 280.0000 | 96.43 | 329.20 | 124.16 | 455.03 |
| Low | 278.3400 | 95.37 | 323.55 | 121.38 | 446.01 |
| Latest | 278.5000 | 96.34 | 328.97 | 124.07 | 449.53 |
| Change | unch | +1.83 | +4.67 | +2.31 | -5.14 |
| % Change | unch | +1.94% | +1.44% | +1.90% | -1.13% |
| Volume | 100 | 7,709,300 | 1,897,400 | 4,659,400 | 1,295,500 |
| 20-Day Average Volume | 205 | 5,177,365 | 2,675,875 | 6,259,690 | 1,349,160 |
| Previous Close | 278.5000 | 94.51 | 324.30 | 121.76 | 454.67 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 277.9430 | 92.76 | 328.76 | 122.61 | 458.61 |
| 20-Day Raw Stochastic | 62.22% | 97.56% | 43.32% | 68.28% | 14.44% |
| 20-Day Relative Strength | 50.53 | 64.50 | 51.85 | 52.93 | 49.96 |
| Weighted Alpha | +62.70 | +48.55 | +21.34 | +30.99 | +6.91 |
| Today's Opinion | N/A | 100% Buy | 64% Buy | 72% Buy | 64% Buy |
| Previous Opinion | N/A | 100% Buy | 48% Buy | 40% Buy | 64% Buy |
| Last Month's Opinion | N/A | 88% Buy | 72% Buy | 56% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.89% since 10/27/17 | +1.24% since 01/07/26 | -3.71% since 01/07/26 | -0.23% since 01/07/26 | -7.15% since 01/07/26 |
| Low | 278.3400 on 11/06/17 | 92.78 on 01/13/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 446.01 on 01/14/26 |
| High | 280.0000 on 11/06/17 | 96.43 on 01/14/26 | 341.46 on 01/08/26 | 125.11 on 01/08/26 | 485.69 on 01/08/26 |
| 1-Month | |||||
| %Chg | +0.67% since 10/06/17 | +7.25% since 12/12/25 | +3.53% since 12/12/25 | +3.05% since 12/12/25 | -0.56% since 12/12/25 |
| Low | 276.0300 on 10/27/17 | 89.53 on 01/05/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 443.12 on 01/05/26 |
| High | 280.0000 on 11/06/17 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 127.41 on 12/23/25 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | +0.29% since 08/04/17 | +13.18% since 10/14/25 | +11.95% since 10/14/25 | +4.72% since 10/14/25 | +9.05% since 10/14/25 |
| Low | 276.0300 on 10/27/17 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 403.16 on 11/04/25 |
| High | 280.0000 on 11/06/17 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | +0.67% since 05/05/17 | +34.29% since 07/14/25 | +10.75% since 07/14/25 | +10.69% since 07/14/25 | -4.83% since 07/14/25 |
| Low | 273.5000 on 06/14/17 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 362.50 on 08/11/25 |
| High | 285.0500 on 05/25/17 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 29,891,406 | 293,118,208 | 174,629,376 | 151,065,216 | 115,358,416 |
| Shares Outstanding, K | 107,330 | 3,101,452 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 2,454,930,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | 707,040,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | N/A | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | N/A | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.54 | 0.34 | 0.45 | 0.33 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 01/01/70 | 02/10/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 35.21 | 20.49 | 14.89 | 14.97 | 30.08 |